1219-胶质瘤类器官平台预测个性化药物反应 episode artwork

EPISODE · Jul 2, 2026 · 23 MIN

1219-胶质瘤类器官平台预测个性化药物反应

from 聊聊Sci

这项研究介绍了一种患者来源的多形性胶质母细胞瘤类器官(GBO)平台,用于精准医疗和药物筛选。研究人员成功建立了能够保留原始肿瘤组织病理学、基因组及转录组特征的类器官模型,使其成为模拟人类疾病的理想工具。实验结果显示,该平台的药物敏感性测试(GBO-DST)在预测患者对替莫唑胺(TMZ)的临床反应方面,比传统的MGMT启动子甲基化状态更为精准。此外,通过深入的转录组分析,研究揭示了肿瘤产生先天性和获得性耐药的多种机制,如错配修复缺陷及基因表达上调。最后,该研究利用类器官筛选出了拉泽替尼(lazertinib)等潜在药物,为耐药性胶质母细胞瘤提供了新的治疗选择。References:Park J, Qiu M, Cho E J, et al. Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma[J]. Cell Reports Medicine, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jul 2, 2026

Embed this episode

Ready to play

1219-胶质瘤类器官平台预测个性化药物反应

0:00 23:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 23 minutes long.

When was this 聊聊Sci episode published?

This episode was published on July 2, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!